Radiologists interpreted 99.29% (17,698,360) of CT exams, while nonradiologists read 0.71% (125,937). And of the 4,512,627 MRIs performed, radiologists read 99.04% of those, while their nonradiologist peers interpreted 0.96%. Similar disparities were found among PET and nuclear medicine studies, with cardiologists interpreting about 3% of all advanced imaging exams. Continue reading →

The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference. Continue reading →

RENO Following a collaborative recruitment between the University of Nevada, Reno School of Medicine and Carson Tahoe Health, Lorrel Toft, M.D., F.A.C.C., a cardiovascular critical care physician and researcher, has been recruited as an associate professor for UNR Meds Department of Internal Medicine as well as a cardiologist on staff with Carson Tahoe Health. Dr. Continue reading →

Remote monitoring and high-tech health management solutions have dominated cardiology headlines for the better part of the past year, touted for their accessibility and preventive benefits. But that vision of remote monitoring as the future of CV care might be a skewed representation of our current reality Continue reading →

November 7, 2019 There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) following B-Laser atherectomy, according to late-breaking study results from the DCB Versus POBA After B-Laser Atherectomy Trial at the Vascular InterVentional Advances (VIVA) Annual Meeting Continue reading →

PRESIDENTIAL SESSION Tuesday, 12:45 pmThis years presidential session, with remarks by American Heart Association CEO Nancy Brown, will also feature select song performances by theater stars from the Broadway hit Hamilton. The Conner Presidential Address will be given by distinguished cardiologist Robert A. Harrington, and the Keynote Address will be delivered by Murat Sonmez of the World Economic Forum. Continue reading →

November 6, 2019 Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at Vascular Interventional Advances (VIVA) meeting in Las Vegas. Continue reading →

The U.S. Food and Drug Administration (FDA) division that handles new and existing oncology drugs was renamed and restructured. The agencys Center for Drug Evaluation and Research (CDER) Office of Hematology and Oncology Products (OHOP) is now the CDERs Office of Oncologic Diseases (OOD) Continue reading →

Study Highlights: News Release, American Heart Association DALLAS, Oct. Continue reading →

November 6, 2019 Positive, two-year data from the first-in-human study of Selution SLR, MedAlliances novel sirolimus-eluting balloon, was presented at VIVA 2019 by Principal Investigator Professor Thomas Zeller, M.D., Ph.D., Universitaets-Herzzentrum, Bad Krozingen, Germany. The study involved 50 patients treated with the investigational device in lesions of the superficial femoral artery (SFA) and popliteal artery. Continue reading →